Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timon E Adolph

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.
Scientific Reports|November 13, 2020
Cardioprotective effects of short-term empagliflozin treatment in db/db miceBernhard Radlinger, Florian Hornsteiner, Sabrina Folie, et al.
Gut Microbes|July 5, 2022
Recovery of <i>Bacteroides thetaiotaomicron</i> ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.
Gut|February 22, 2014
Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regenerationMarkus Tschurtschenthaler, Jun Wang, Cornelia Fricke, et al.
Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
International Journal of Obesity (2005)|January 15, 2022
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulationJulian Schwärzler, Lisa Mayr, Bernhard Radlinger, et al.
Clinical and Translational Gastroenterology|January 13, 2021
Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19Felix Grabherr, Maria Effenberger, Alisa Pedrini, et al.
Nature Communications|July 14, 2022
Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicityJoachim Hanna, Flavio Beke, Louise M O'Brien, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.
Scientific Reports|November 13, 2020
Cardioprotective effects of short-term empagliflozin treatment in db/db miceBernhard Radlinger, Florian Hornsteiner, Sabrina Folie, et al.
Gut Microbes|July 5, 2022
Recovery of <i>Bacteroides thetaiotaomicron</i> ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.
Gut|February 22, 2014
Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regenerationMarkus Tschurtschenthaler, Jun Wang, Cornelia Fricke, et al.
Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
International Journal of Obesity (2005)|January 15, 2022
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulationJulian Schwärzler, Lisa Mayr, Bernhard Radlinger, et al.
Clinical and Translational Gastroenterology|January 13, 2021
Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19Felix Grabherr, Maria Effenberger, Alisa Pedrini, et al.
Nature Communications|July 14, 2022
Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicityJoachim Hanna, Flavio Beke, Louise M O'Brien, et al.
Pageof 7